Screener
TG Therapeutics TGTX Long-term investments
Long-term investments at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's long-term investments?
- TG Therapeutics (TGTX) reported long-term investments of $69.67M in Q2 2026.
- How has TG Therapeutics's long-term investments changed year-over-year?
- TG Therapeutics's long-term investments decreased by 43.2% year-over-year, from $122.74M to $69.67M.
- What is the long-term trend for TG Therapeutics's long-term investments?
- Over 3 years (2022 to 2025), TG Therapeutics's long-term investments has grown at a 1.9% compound annual growth rate (CAGR), from $59.37M to $62.82M.
- What does long-term investments mean?
- Equity investments, venture capital, strategic stakes, and other investments with holding periods expected to exceed one year.
Ask your AI about TG Therapeutics's long-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude